39 results
DEFM14A
SQZB
SQZ Biotechnologies Co
23 Jan 24
Proxy related to merger
4:31pm
Management.
On September 29, 2023, the Company announced a restructuring, pursuant to which it would cease substantially all research and development … reduction of approximately 80% of our remaining employees and the decision to cease substantially all research and development activities to reduce our
PREM14A
SQZB
SQZ Biotechnologies Co
12 Jan 24
Preliminary proxy related to merger
8:57am
substantially all research and development activities and reduce its work force by approximately 80% to reduce ongoing operating expenses in furtherance … ”) and ceased substantially all research and development activities to reduce our ongoing operating expenses while we pursued strategic alternatives. Should
PRE 14A
pbknuoi4xle6ui
10 Apr 23
Preliminary proxy
4:31pm
8-K
1mveixglxw
19 May 22
Regulation FD Disclosure
4:05pm
S-3
alpzdonh4mhrlrsegf2q
12 Nov 21
Shelf registration
12:00am
8-K/A
1iglsy2 p42uywid
29 Jul 21
Departure of Directors or Certain Officers
5:00pm